Fairmount Funds Management LLC
Position in APGE — Apogee Therapeutics, Inc.
CIK 1802528
WEST CONSHOHOCKEN, PA
Position in APGE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$39,639,416
+$14,502,299 QoQ
Shares Held
298,647
0.0% QoQ
Ownership
0.395%
of shares outstanding
% of Portfolio
2.62%
of 13F equity value
Holder Rank
#48
of 285 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in APGE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Fairmount Funds Management LLC holds $1,512,967,792 across 12 Biotechnology names. APGE ranks #10 (2.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ORKA |
Oruka Therapeutics, Inc.
|
3,705,262 | $352,629,784 | |
| 2 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
2,537,191 | $247,325,378 | |
| 3 | DMRA |
Damora Therapeutics, Inc.
|
8,713,000 | $226,625,130 | |
| 4 | COGT |
Cogent Biosciences, Inc.
|
5,503,418 | $212,982,276 | |
| 5 | JBIO |
Jade Biosciences, Inc.
|
4,553,494 | $101,178,636 | |
| 6 | ELVN |
Enliven Therapeutics, Inc.
|
1,855,644 | $94,173,933 | |
| 7 | VRDN |
Viridian Therapeutics, Inc.\DE
|
5,090,928 | $93,520,347 | |
| 8 | ZBIO |
Zenas BioPharma, Inc.
|
2,359,025 | $59,872,054 |
All Filings in APGE
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $39,639,416 | 298,647 | Shares | Sole | 2026-08-14 | |
| 2026-06-18 | $606,767,847 | 6,713,519 | Shares | Sole | 2026-06-23 | |
| 2026-03-31 | $25,137,117 | 298,647 | Shares | Sole | 2026-05-15 | |
| 2026-03-26 | $522,773,755 | 6,666,332 | Shares | Sole | 2026-03-27 | |
| 2026-01-22 | $475,038,026 | 5,948,385 | Shares | Sole | 2026-01-22 | |
| 2025-12-31 | $154,631,875 | 2,048,647 | Shares | Sole | 2026-02-17 | |
| 2025-10-10 | $297,937,200 | 5,678,239 | Shares | Sole | 2025-10-14 | |
| 2025-09-30 | $81,392,745 | 2,048,647 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $88,972,739 | 2,048,647 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $76,537,451 | 2,048,647 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $92,803,709 | 2,048,647 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $120,337,524 | 2,048,647 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $80,614,259 | 2,048,647 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $136,132,593 | 2,048,647 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $82,176,457 | 2,941,176 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $62,647,048 | 2,941,176 | Shares | Sole | 2023-11-14 | |
| No filing history on record for this holder in this stock. | ||||||